You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 7, August 18, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Preimplantation Testing to Produce an HLA-Matched Donor Infant

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Both Dr Verlinsky and colleagues1 and Dr Fost2 argue that in vitro fertilization (IVF) with preimplantation HLA matching poses no risk of creating a donor child with either DBA or acute leukemia. However, the procedure may inadvertently transfer unidentified DBA genes, as cases of DBA have now been identified in which the disorder is inherited from a parent with a "silent phenotype" in whom there are no hematologic or nonhematologic manifestations.3-5 These instances underscore the unpredictability of the disease and the possibility that what may appear to be sporadic mutations are actually inherited. This is further complicated in that later prenatal testing is not possible in those cases for which the responsible mutation remains unidentified. Therefore, preimplantation HLA testing to create a donor may inadvertently result in a child affected by the disorder. Indeed, neither article clarifies whether any of these 9 cases had been rejected by . . . [Full Text of this Article]

John E. Wagner, MD
Blood and Marrow Transplantation Program and Stem Cell Institute
School of Medicine

Jeffrey P. Kahn, PhD, MPH
kahnx009@umn.edu
Center for Bioethics

Susan M. Wolf, JD
School of Law
University of Minnesota
Minneapolis

Jeffrey M. Lipton, MD, PhD
Division of Pediatric Hematology/Oncology and Stem Cell Transplantation
Schneider Children's Hospital
Albert Einstein College of Medicine
New Hyde Park, NY



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Preimplantation Testing to Produce an HLA-Matched Donor Infant
Anders Fasth and Jan Wahlström
JAMA. 2004;292(7):803.
EXTRACT | FULL TEXT  

Preimplantation Testing to Produce an HLA-Matched Donor Infant—Reply
Anver Kuliev, Svetlana Rechitsky, and Yury Verlinsky
JAMA. 2004;292(7):804.
EXTRACT | FULL TEXT  

Preimplantation Testing to Produce an HLA-Matched Donor Infant—Reply
Norman C. Fost
JAMA. 2004;292(7):804.
EXTRACT | FULL TEXT  

Preimplantation HLA Testing
Yury Verlinsky, Svetlana Rechitsky, Tatyana Sharapova, Randy Morris, Mohammed Taranissi, and Anver Kuliev
JAMA. 2004;291(17):2079-2085.
ABSTRACT | FULL TEXT  

Conception for Donation
Norman C. Fost
JAMA. 2004;291(17):2125-2126.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.